Literature DB >> 15229298

Mutational analysis of the highly conserved ERY motif of the thromboxane A2 receptor: alternative role in G protein-coupled receptor signaling.

Valérie Capra1, Alessio Veltri, Chiara Foglia, Luca Crimaldi, Aïda Habib, Marco Parenti, G Enrico Rovati.   

Abstract

The presence of highly conserved amino acid stretches in G protein-coupled receptors (GPCRs) usually predicts an important role in receptor function. Considerable attention has therefore been focused on the involvement of the highly conserved Glu/Asp-Arg-Tyr (E/DRY) motif at the cytoplasmic end of transmembrane domain 3 in the regulation of GPCR conformational states and/or the mediation of G protein activation. In the present study, we investigated the role of Glu129 and Arg130 in the ERY of thromboxane A2 receptor alpha (TPalpha) in transfected human embryonic kidney 293 cells. We show that no conservative or nonconservative substitutions of Glu129 and Arg130 generated a constitutively active TPalpha mutant, but a nonconservative mutation of Arg130 (R130V) yielded a mutant receptor with significantly impaired 9,11-dideoxy-9alpha,11alpha-methanoepoxy-prosta-5Z,13E-dien-1-oic acid (U46619)-induced accumulation of inositol phosphates (IPs). This loss-of-function phenotype seems to be caused by the uncoupling of the TPalpha receptor from Gq, as demonstrated by the loss of high-affinity agonist binding, and not by receptor internalization, as shown by localization studies with the R130V-green fluorescent protein fusion protein. It is interesting to note that U46619-induced activation of the nonconservative E129V mutant stimulated the production of IPs with a approximately 10-fold lower EC50 and a approximately 2-fold higher Emax than in the wild-type receptor. Collectively, these data demonstrate that, unlike other GPCRs, mutations of Glu129 do not induce constitutive activity, whereas Arg130 is involved in G protein coupling or recognition, and they suggest the existence within class A GPCRs of at least two different subclasses that make different uses of the highly conserved E/DRY motif.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15229298     DOI: 10.1124/mol.104.001487

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  23 in total

1.  Mutations of CB1 T210 produce active and inactive receptor forms: correlations with ligand affinity, receptor stability, and cellular localization.

Authors:  Aaron M D'Antona; Kwang H Ahn; Debra A Kendall
Journal:  Biochemistry       Date:  2006-05-02       Impact factor: 3.162

2.  Superactive mutants of thromboxane prostanoid receptor: functional and computational analysis of an active form alternative to constitutively active mutants.

Authors:  Manuela Ambrosio; Francesca Fanelli; Silvia Brocchetti; Francesco Raimondi; Mario Mauri; G Enrico Rovati; Valérie Capra
Journal:  Cell Mol Life Sci       Date:  2010-04-11       Impact factor: 9.261

3.  Common structural requirements for heptahelical domain function in class A and class C G protein-coupled receptors.

Authors:  Virginie Binet; Béatrice Duthey; Jennifer Lecaillon; Claire Vol; Julie Quoyer; Gilles Labesse; Jean-Philippe Pin; Laurent Prézeau
Journal:  J Biol Chem       Date:  2007-02-19       Impact factor: 5.157

4.  Characterization of intracellular signaling mediated by human somatostatin receptor 5: role of the DRY motif and the third intracellular loop.

Authors:  Erika Peverelli; Andrea G Lania; Giovanna Mantovani; Paolo Beck-Peccoz; Anna Spada
Journal:  Endocrinology       Date:  2009-04-02       Impact factor: 4.736

5.  Assembling NMR structures for the intracellular loops of the human thromboxane A2 receptor: implication of the G protein-coupling pocket.

Authors:  Jiaxin Wu; Mary Feng; Ke-He Ruan
Journal:  Arch Biochem Biophys       Date:  2007-12-03       Impact factor: 4.013

6.  Antagonism of thromboxane receptors by diclofenac and lumiracoxib.

Authors:  E Selg; C Buccellati; M Andersson; G E Rovati; M Ezinga; A Sala; A-K Larsson; M Ambrosio; E Ambrosio; L Låstbom; V Capra; B Dahlén; A Ryrfeldt; G C Folco; S-E Dahlén
Journal:  Br J Pharmacol       Date:  2007-10-29       Impact factor: 8.739

7.  A novel thromboxane A2 receptor D304N variant that abrogates ligand binding in a patient with a bleeding diathesis.

Authors:  Andrew D Mumford; Ban B Dawood; Martina E Daly; Sherina L Murden; Michael D Williams; Majd B Protty; Jennifer C Spalton; Mark Wheatley; Stuart J Mundell; Steve P Watson
Journal:  Blood       Date:  2009-10-14       Impact factor: 22.113

8.  New insights into human prostacyclin receptor structure and function through natural and synthetic mutations of transmembrane charged residues.

Authors:  J Stitham; E Arehart; S R Gleim; N Li; K Douville; J Hwa
Journal:  Br J Pharmacol       Date:  2007-08-20       Impact factor: 8.739

9.  Identification of xenoestrogens in food additives by an integrated in silico and in vitro approach.

Authors:  Alessio Amadasi; Andrea Mozzarelli; Clara Meda; Adriana Maggi; Pietro Cozzini
Journal:  Chem Res Toxicol       Date:  2009-01       Impact factor: 3.739

10.  Functional analysis of the murine cytomegalovirus chemokine receptor homologue M33: ablation of constitutive signaling is associated with an attenuated phenotype in vivo.

Authors:  Ruth Case; Emma Sharp; Tau Benned-Jensen; Mette M Rosenkilde; Nicholas Davis-Poynter; Helen E Farrell
Journal:  J Virol       Date:  2007-12-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.